These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 34813140)

  • 1. Mammalian Chemical Genomics towards Identifying Targets and Elucidating Modes-of-Action of Bioactive Compounds.
    Matsumoto K; Yoshida M
    Chembiochem; 2022 Apr; 23(7):e202100561. PubMed ID: 34813140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in target identification of bioactive natural products.
    Yoshida M
    Biosci Biotechnol Biochem; 2019 Jan; 83(1):1-9. PubMed ID: 30343630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical-genetic approaches for exploring the mode of action of natural products.
    Lopez A; Parsons AB; Nislow C; Giaever G; Boone C
    Prog Drug Res; 2008; 66():237, 239-71. PubMed ID: 18416308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining the mode of action of bioactive compounds.
    Azad MA; Wright GD
    Bioorg Med Chem; 2012 Mar; 20(6):1929-39. PubMed ID: 22300885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional genomic screening approaches in mechanistic toxicology and potential future applications of CRISPR-Cas9.
    Shen H; McHale CM; Smith MT; Zhang L
    Mutat Res Rev Mutat Res; 2015; 764():31-42. PubMed ID: 26041264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical genomics reveals mechanistic hypotheses for uncharacterized bioactive molecules in bacteria.
    French S; Ellis MJ; Coutts BE; Brown ED
    Curr Opin Microbiol; 2017 Oct; 39():42-47. PubMed ID: 28957731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying synthetic lethal targets using CRISPR/Cas9 system.
    Dhanjal JK; Radhakrishnan N; Sundar D
    Methods; 2017 Dec; 131():66-73. PubMed ID: 28710008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct and indirect approaches to identify drug modes of action.
    Tulloch LB; Menzies SK; Coron RP; Roberts MD; Florence GJ; Smith TK
    IUBMB Life; 2018 Jan; 70(1):9-22. PubMed ID: 29210173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical-genomic profiling: systematic analysis of the cellular targets of bioactive molecules.
    Andrusiak K; Piotrowski JS; Boone C
    Bioorg Med Chem; 2012 Mar; 20(6):1952-60. PubMed ID: 22261022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A natural products approach to drug discovery: probing modes of action of antitumor agents by genome-scale cDNA library screening.
    Luesch H; Abreu P
    Methods Mol Biol; 2009; 572():261-77. PubMed ID: 20694698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bugs, drugs and chemical genomics.
    Roemer T; Davies J; Giaever G; Nislow C
    Nat Chem Biol; 2011 Dec; 8(1):46-56. PubMed ID: 22173359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target deconvolution of bioactive small molecules: the heart of chemical biology and drug discovery.
    Jung HJ; Kwon HJ
    Arch Pharm Res; 2015 Sep; 38(9):1627-41. PubMed ID: 26040984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining functional genomics and chemical biology to identify targets of bioactive compounds.
    Ho CH; Piotrowski J; Dixon SJ; Baryshnikova A; Costanzo M; Boone C
    Curr Opin Chem Biol; 2011 Feb; 15(1):66-78. PubMed ID: 21093351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating yeast chemical genomics and mammalian cell pathway analysis.
    Zhou FL; Li SC; Zhu Y; Guo WJ; Shao LJ; Nelson J; Simpkins S; Yang DH; Liu Q; Yashiroda Y; Xu JB; Fan YY; Yue JM; Yoshida M; Xia T; Myers CL; Boone C; Wang MW
    Acta Pharmacol Sin; 2019 Sep; 40(9):1245-1255. PubMed ID: 31138898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of bioactive small molecule target through phenotypic screening.
    Cho YS; Kwon HJ
    Bioorg Med Chem; 2012 Mar; 20(6):1922-8. PubMed ID: 22153994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SGC beyond structural genomics: redefining the role of 3D structures by coupling genomic stratification with fragment-based discovery.
    Bradley AR; Echalier A; Fairhead M; Strain-Damerell C; Brennan P; Bullock AN; Burgess-Brown NA; Carpenter EP; Gileadi O; Marsden BD; Lee WH; Yue W; Bountra C; von Delft F
    Essays Biochem; 2017 Nov; 61(5):495-503. PubMed ID: 29118096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-Wide CRISPR/Cas9 Screening for Identification of Cancer Genes in Cell Lines.
    Adelmann CH; Wang T; Sabatini DM; Lander ES
    Methods Mol Biol; 2019; 1907():125-136. PubMed ID: 30542996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural products-prompted chemical biology: phenotypic screening and a new platform for target identification.
    Kakeya H
    Nat Prod Rep; 2016 May; 33(5):648-54. PubMed ID: 26883503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Phenotypic Hit to Chemical Probe: Chemical Biology Approaches to Elucidate Small Molecule Action in Complex Biological Systems.
    Pasquer QTL; Tsakoumagkos IA; Hoogendoorn S
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33287212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidating drug targets and mechanisms of action by genetic screens in mammalian cells.
    Kampmann M
    Chem Commun (Camb); 2017 Jun; 53(53):7162-7167. PubMed ID: 28487920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.